Literature DB >> 21206242

Predictors of patient and caregiver distress in an adult sample with bipolar disorder seeking family treatment.

Allison M R Lee1, Daphne Simeon, Lisa J Cohen, Janine Samuel, Annie Steele, Igor I Galynker.   

Abstract

Little is known about the potentially unique sources of distress in populations seeking family-oriented treatment for bipolar disorder. The present study aimed to characterize this new treatment population by measuring depression, anxiety, quality of life, knowledge of bipolar disorder, therapeutic alliance, and mental illness stigma in 43 bipolar patients and 41 caregivers at family treatment intake. In all, 50% of patients and 27.6% of caregivers had significant depressive symptoms, whereas 51.2% of patients and 45.5% of caregivers had significant anxiety symptoms. Caregiver anxiety was inversely related to patient anxiety, stigma, and poor alliance. Treatment nonadherence was associated with more anxiety and stigma in patients and less anxiety in caregivers. In summary, family-oriented bipolar treatment seekers are significantly distressed at intake, and may benefit from lowering anxiety and stigma in patients and raising awareness and concern in caregivers. Future research should further clarify the complex relationships between caregiver and patient symptoms and attitudes.

Entities:  

Mesh:

Year:  2011        PMID: 21206242     DOI: 10.1097/NMD.0b013e3182043b73

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  2 in total

1.  Examination of Gender Differences in the Influence of Social Support on Psychological Distress in Canadian Adults with Bipolar Disorder.

Authors:  Christie D Warren; Ken Fowler
Journal:  Psychiatr Q       Date:  2021-03-03

2.  The influence of social support on psychological distress in Canadian adults with bipolar disorder.

Authors:  Christie D Warren; Ken Fowler; David Speed; Anna Walsh
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2018-05-08       Impact factor: 4.328

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.